Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haerim Chung

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cancer Research and Treatment|August 6, 2021
Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective StudyYu Ri Kim, Soo-Jeong Kim, Hye Sun Lee, et al.
Blood Research|October 19, 2017
Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experienceJung Yeon Lee, Haerim Chung, Hyunsoo Cho, et al.
Journal for Immunotherapy of Cancer|January 8, 2024
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myelomaSojeong Kim, Haerim Chung, Jeong-Eun Kwak, et al.
Scientific Reports|May 18, 2022
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myelomaJihye Ha, Hyunsoo Cho, Taek Gyu Lee, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma PatientsJihye Ha, Hyeonah Lee, Saeam Shin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2016
A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphomaJi Eun Jang, Yu Ri Kim, Soo-Jeong Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple MyelomaHyunsoo Cho, Kyung Hwan Kim, Hoyoung Lee, et al.
The Korean Journal of Internal Medicine|June 20, 2020
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphomaYu Ri Kim, Soo-Jeong Kim, June-Won Cheong, et al.
Annals of Hematology|May 12, 2020
Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphomaYu Ri Kim, Sun Och Yoon, Soo-Jeong Kim, et al.
Cancer Medicine|August 12, 2020
Immunosuppressive role of CD11b<sup>+</sup> CD33<sup>+</sup> HLA-DR<sup>-</sup> myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemiaShin Young Hyun, Eun Jung Na, Ji Eun Jang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cancer Research and Treatment|August 6, 2021
Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective StudyYu Ri Kim, Soo-Jeong Kim, Hye Sun Lee, et al.
Blood Research|October 19, 2017
Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experienceJung Yeon Lee, Haerim Chung, Hyunsoo Cho, et al.
Journal for Immunotherapy of Cancer|January 8, 2024
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myelomaSojeong Kim, Haerim Chung, Jeong-Eun Kwak, et al.
Scientific Reports|May 18, 2022
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myelomaJihye Ha, Hyunsoo Cho, Taek Gyu Lee, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma PatientsJihye Ha, Hyeonah Lee, Saeam Shin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2016
A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphomaJi Eun Jang, Yu Ri Kim, Soo-Jeong Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple MyelomaHyunsoo Cho, Kyung Hwan Kim, Hoyoung Lee, et al.
The Korean Journal of Internal Medicine|June 20, 2020
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphomaYu Ri Kim, Soo-Jeong Kim, June-Won Cheong, et al.
Annals of Hematology|May 12, 2020
Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphomaYu Ri Kim, Sun Och Yoon, Soo-Jeong Kim, et al.
Cancer Medicine|August 12, 2020
Immunosuppressive role of CD11b<sup>+</sup> CD33<sup>+</sup> HLA-DR<sup>-</sup> myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemiaShin Young Hyun, Eun Jung Na, Ji Eun Jang, et al.
Pageof 4